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1. INTRODUCTION 
Medicinal chemistry involves the discovery, development, identification and 
interpretation of the mode of action of biologically active compounds at the molecular 
level. Emphasis is put on drugs, but the significance of medicinal chemistry is also 
concerned with the study, identification and synthesis of the metabolic products of drugs 
and related compounds. Medicinal chemistry covers three critical steps. 
A discovery step, involves the choice of the therapeutic target (receptor, enzyme, 
transport group, cellular, or in vivo model) and the identification (or discovery) and 
production of new active substances interacting with the selected target. Such compounds 
are usually called lead compounds; they can originate from synthetic organic chemistry, 
from natural sources, or from biotechnological process. Drugs design aims at the 
development of the drugs with high specificity and therapeutic indeed. 
An optimization step, which deals with the improvement of the lead structure. 
The optimization process takes primarily in to account the increase in potency, selectivity 
and toxicity. Its characteristics are the establishment and analysis of structure activity 
relationships, in an ideal context to enable the understanding of the molecular mode of 
action. However, an assessment of the pharmacokinetic parameters such as absorption, 
distribution, metabolism, excretion and oral bioavailability is almost systematically 
practiced at an early stage of the development in order to eliminate unsatisfactory 
candidates. 
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A development step, whose purpose is the continuation of the improvement of 
the pharmacokinetic properties and the fine tuning of the pharmaceutical properties 
(chemical formulation) of the active substances in order to render them suitable for 
clinical use.  This chemical formulation process can consist in the preparation of better 
absorbed compounds, of sustained release formulations, and of water soluble derivatives 
or in the elimination of properties related to the patient’s compliance (causticity, 
irritation, painful injections and undesirable organoleptic properties.) 
Benzimidazoles are five membered benzoheterocyclic compounds containing two 
hetero atoms. Both hetero atoms are nitrogen, which are present at non-adjacent position. 
Benzimidazole derivatives belong to a crucial structural motif that is seen in many 
pharmaceutically and biologically interesting molecules. Recent publications have been 
reported to possess a number of significant and diverse biological activities such as 
fungicide, anti-oxidant, anti-microbial, anthelmintic, anti-cancer, anti-hypertensive, anti-
neoplastic, anti-inflammatory, analgesic, anti-protozoal, and anti-hepatitis B virus 
activity. Some of their analogues show an array of biological activities, including non-
nucleoside HIV-1 reverse transcriptase inhibitors and they selective inhibitors of 
cyclooxygenase Cox-2. 
In view of these activities and synthetic importance, benzimidazole core and its 
various derivatives have long been an area of interest and still continue as an active 
domain for research and industrial field. These versatile biological significance inspired 
us to synthesize the 2, 5 di-substituted benzimidazoles. 
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Traditional synthesis involves the reaction between a O-phenylene diamine and a 
carboxylic acid under harsh dehydrating reaction conditions. A number of synthetic 
methods have been developed in recent years to uncover a variety of new reagents for the 
synthesis of 2-substituted benzimidazole under milder conditions by the addition of lewis 
acids, inorganic clays and mineral acids. Long reaction time for this reaction has been 
reduced by the use of microwave heating, both with and without polyphosporic acid. 
Benzimidazole (Anonymous http:// www.wikipedia.org) 
Structure: 
                                                          
N
N
H  
 Formula      :  C7 H6 N2 
Molecular weight :  118.17 
Toxicity  :  Oral rat LD50:2910mg/Kg 
Synonyms  :  1H-Benzimidazole; 1,3-benzodiazole;benzoglyoxaline; 3-
azindole; N,N’methylenyl-O-phenylenediamine; 3-azaindole;O-benzimidazole; 
benzoimidazole; BZI; 1,3diazaindene. 
Physical and chemical properties: 
Melting point           :   176° C 
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Boiling point  : 360° C 
Specific gravity : 1 
Solubility in water : slightly soluble 
Auto ignition  : 538° C 
Stability  :   Stable under normal temperature and condition. 
 Special interest of researchers triggered by the fact that 5, 6-dimethyl 
benzimidazole is a component of naturally occurring vitamin B12. A large number of 
benzimidazole derivatives were shown to exhibit important biological properties such as 
anti bacterial, anti fungal, anti-helminthic, anti-allergic, anti-neoplastic, local analgesic, 
antihistaminic, anti-leishmanial, vasodilator, anti-hypertensive, spasmolytic, and anti-
ulcer activities. (Hasan Kucukbay, et al., 2010). A large variety of 2-substituted 
benzimidazoles have been found to posses anti inflammatory, anti-spasmodic, anti 
histaminic, antimicrobial, anticancer and cyclooxygenase inhibitor activity. (Gupta S.K et 
al., 2010) 
 Also, some benzimidazole nucleosides, particularly 5, 6-dichloro 
benzimidazole-1-β-D-ribofuranoside (DRB) and its 2-substituted derivatives show 
activity against human cytomegalovirus. It is also known that 5, 6-dinitro benzimidazole 
can substitute 5, 6-dimethyl benzimidazole in the vitamin B12 molecule in coryne 
bacterium diphtheria and 2-trifluoro benzimidazoles are potent (Zygmunt Kazimierczuk, 
et al., 2002). Benzimidazole derivatives exhibit significant activity against several viruses 
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such as HIV, herpes (HSV-1), RNA, influenza, and human cytomegalovirus (HCMV). 
(Han xiangming et al., 2007) 
Benzimidazole substituted with a sugar residue at C-2 is potent inhibitors of 
glycogen phosphorylase and have become the targets for new drug development for 
treatment of diabetes mellitus. (Leonard J.T et al., 2007) 
N
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Fig-1: Compounds containing benzimidazole nucleus 
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Fig-1: Compounds containing benzimidazole nucleus (contd) 
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Although a variety of benzimidazole derivatives are known, the development of 
new and convenient strategies to synthesize new biologically active benzimidazole is of 
considerable interest. (Gupta S.K etal., 2010) 
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2. LITERATURE REVIEW 
2.1) Ayhan Kilcig G. et al., 2006 synthesized some novel benzimidazole derivatives and 
they were evaluated for their anti-fungal activities against Candida albicans, Candida 
glabrata and Candida krusei. Compounds 1 and 2 (Fig-2) possessed good anti-fungal 
activity comparable to Fluconazole against Candida albicans.  
            1
N
NNH2
F
C3H7
2
N
NO2N
F
C3H7
 
(Fig-2) 
2.2) Ansari K.F. et al., 2009 developed a series of 2-substituted-1-[{(5-substituted 
alkyl/aryl)-1,3,4-oxadiazol-2-yl}methyl]-1H-benzimidazole derivatives, the synthesized 
compounds were identified by spectral and elemental methods of analyses. All the 
synthesized compounds were screened for their anti-microbial activities. All of the 
derivatives showed good activity towards gram-positive bacteria and negligible activity 
towards gram-negative bacteria. Some of the synthesized compounds (Fig-3) showed 
good activity against tested fungi.  
              
N
N
R
O
N N
R1    (Fig-3) 
 
Code R R1 
1 H 2-ClC6H4 
2 H 4-ClC6H4 
3 H 2-OHC6H4 
9 
 
 
 
 
  
 2.3) OztekinAlgul et al., 2007 investigated the structure-activity relationship for some 
newly synthesized benzimidazole structures and they were synthesized 2-substituted 
benzimidazole derivatives. The synthesized compounds were examined for anti-bacterial 
activity against both gram-positive (Enterococcus faecalis, Staphylococcus epidermis) 
and gram-negative (Escherichia coli, Pseudomonas aeurginosa) organisms and anti-
fungal activity against Candida albicans, Candida kruesi, Candida glabrata, Candida 
tropicalis and Candida parapsilosis. All of the compounds (Fig-4) were more active 
towards bacteria than fungi.  
     
N
N
H
R
R
1
 
                      (Fig-4) 
2.4) Jitender Singh et al., 2010 synthesized a series of 1, 2, 5-tri substituted 
benzimidazole derivatives and the derivatives were examined for anti-convulsant activity. 
The results of QSAR investigation and the study of various Physiochemical properties 
indicates that the change in linker position (R) does not change the activity, the 
compound 6f and 6j (Fig-5) possessed good anti-convulsant activity.  
N
N
R
N
O2N
(Fig-5)                              
Compound R R1 
1 CH2OH H 
2 CH2OH CH3 
4 CH2NH2 H 
5 CH3 H 
6 CH2SH H 
Compound R 
6f H 
6j CH3 
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2.5) Jat Rakesh Kumar., et al 2006 developed a new series of 5-substituted (amino) -2- 
phenyl-1-(2-carboxy biphenyl-4-yl) benzimidazole derivatives and they were evaluated 
for anti-hypertensive activity. From the study it was found that compounds contain ethyl 
group at 2nd position (Fig-6) gave better result compare to phenyl at position 2. 
        
N
N
O2N
CH3
HOOC
 
             (Fig-6) 
 2.6) Ashish Kumar Tewar et al., 2006 synthesized a new series of N-substituted-2-
substituted benzimidazole derivatives, 1-benzyl-2-substituted benzimidazole and            
1-(p-chlorophenyl)-2-substituted benzimidazole derivatives. The synthesized compounds 
were tested for their anti-viral activities against tobacco mosaic virus and sun hemp 
rosette viruses. The compounds 1, 2, 5 and 8 (Fig-7) were showed significant activity.   
    
N
N
R
R
1
 
(Fig-7) 
Compound R R1 
1 CH2CH2COOH CH2C6H5 
2 C6H4OH CH2C6H5 
5 CHOH.CHOH.COOH CH2C6H5 
8 CH2CH2COOH ClC6H5 
Code R R1 
1 CH2CH2COOH CH2C6H5 
2 C6H4OH CH2C6H5 
5 CHOH.CHOH.COOH CH2C6H5 
8 CH2CH2COOH ClC6H5 
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 2.7) Goel P.K. et al., 2007 investigated the quantitative structure activity relationship 
(QSAR) of a set of twenty 1H- benzimidazole derivatives with anti-protozoal activity 
against Entamoeba histolytica. The studies used various combinations of thermodynamic, 
electronic, and spatial descriptors. By assuming the significance of the contributed 
descriptors for the inhibition of amoebic activity, they were synthesized six new 
compounds (BZ1 to BZ6) (Fig-8) for the better inhibitory activity with less toxicity. 
N
N
H
R
1
R
2
R
3
                 (Fig-8) 
2.8) Sreena K. et al., 2009 had synthesized some benzimidazole derivatives and screened 
for their anthelmintic activity. The presences of specific functional group were confirmed 
by IR spectroscopy. The structures for the synthesized compounds were identified by 
NMR and Mass spectral analysis. Among the synthesized compounds 2-phenyl 
benzimidazole (Fig-9) showed potent anthelmintic activity.   
 
N
N
H (Fig-9) 
2.9) Podunacvac-Kuzmanovic  et al., 2009 synthesized a set of benzimidazole derivatives 
and they were tested for their inhibitory activities against the gram negative bacterium 
Pseudomonas aeruginosa and minimum inhibitory concentration were determined for all 
the compounds. Quantitative structure activity relationship (QSAR) analysis was applied 
Code R1 R2 R3 Code R1 R2 R3 
BZ1 Cl H CH2CH3 BZ4 Cl H H2CH2CH3 
BZ2 CH3 H CH2CH3 BZ5 H H H2CH2CH3 
BZ3 CH3 H H2CH2CH3 BZ6 H H CH2CH3 
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to the synthesized derivatives using a combination of various physicochemical, steric, 
electronic, and structural molecular descriptors. From the QSAR result, they concluded 
that the 2-amino and 2-methyl benzimidazole derivatives (Fig-10) are effective in vitro 
against the gram negative bacteria Pseudomonas aeruginosa. 
  
N
N
R1
R2     R2=
O
,  ,  
 
, 
          (Fig-10)  R1 = NH2, CH3 
2.10) Alagoz et al., 2004 carried out the QSAR studies on 4,5,6,7 tetra-bromo 
benzimidazole derivatives. The inhibitory activity data (IC50) and the values converted in 
to –log IC50 (μM). From these values confirmed that compound b (Fig-11) had more 
effective inhibitory concentration. 
    
N
N
H
Br
Br
Br
Br
Br     (Fig-11) 
2.11) Bariwal et al., 2008 synthesized a series of 2-(triflouromethyl)-1H-benzimidazole 
derivatives with 5th and 6th positions having bio isosteric substituent (-Cl, -F, -CF3, -CN). 
Analogues were tested in vitro anti-protozoal activity against the protozoan Giardia 
intestinal and Trichomonas vaginalis compared with albendazole and metronidazole. The 
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below mentioned compound (Fig-12) was more active than albendazole against T. 
vulgaris and also showed moderate anti malarial activity against W2 and D6 strains of 
Plasmodium falciparum. 
    
N
N
H
CF3
F3C
 
     (Fig-12) 
2.12) Alonso et al., 2009 designed a novel and functionalized benzimidazole derivatives. 
Compounds were tested against PDE-1V for potential anti-asthmatic effect, compound a, 
b and c shown inhibitory activity (3.40%, 13.52% and 8.91%) at 1μm doses. The 
compound ‘b’ (Fig-13) showed potential anti-asthmatic activity. 
N
N
R  
   (Fig-13) 
2.13) Simone Budow et al., 2009 synthesized a series of benzimidazole derivatives and 
the β-L- and β-D-2-deoxyribonucleosides substituted benzimidazole tested for anti-viral 
activity against selected RNA and DNA viruses including HIV-1, BVDV, YFV, DENV-
2, WNV, HBV, HCV and human RSV virus. The compounds 1 to 6 (Fig-14) had exhibit 
good antiviral activities.  
Compound R 
A H 
B C2H5 
C CH2CH2CH3 
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 (Fig-14) 
2.14) Andrew et al., 1997 developed a series of 2-(Trifluromethyl)-1H-benzimidazole 
derivatives (Fig-15) with various 5th and 6th position bio-isosteric substituent’s (-Cl, -F, -
CF3, -CN) by using a short synthetic route. Each analogue was tested in vitro against the 
protozoa Giardia intestinalis and Trichomonas vaginalis in comparison with albendazole 
and metronidazole.      
                      
N
N
H
X
CF3
    X = Cl, F, CF3, CN 
     (Fig-15) 
2.15) Mohd Rashid et al., 2011 synthesized 5-amino 2-substituted benzimidazole 
derivatives (Fig-16) in the presence of formalin. The synthesized compounds were tested 
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for anti-bacterial activity. All of the compounds showed good anti-bacterial against the 
growth of Staph. aureus and  E. coli. The amino group at 5th position was important for 
exhibiting inhibitory activity. 
                                  
N
N
H
NH2
R
R = ClC6H4, OHC6H4, Cl2C6H3 
          (Fig-16) 
2.16) Masry et al., 2000 discovered a series of 2-alkyl 1-(4'–benzhydrazide) amino 
methyl benzimidazole derivatives. In which hydrazide derivatives were showed potent 
inhibitory activity towards the enzyme MAO. The newly synthesized benzimidazole 
hydrazides were exhibited Low anti-convulsant activity which was found to be maximum 
with compound R = C2H5 (Fig-17). 
 
N
H2NH2C CONHNH2
CH3
 
   (Fig-17) 
2.17) Gupta S.K. et al.,  2010 synthesized 2-alkyl benzimidazole and 2-aryl 
benzimidazole derivatives by using different acids namely acetic acid, o-chloro benzoic 
acid, benzoic acid and cinnamic acid. These were further treated with tosyl chloride and 
benzoyl chloride to get N-substituted benzimidazole derivatives. Final derivatives were 
tested for anti-microbial activity against Escherichia coli, Pseudomonas aeruginosa and 
staphylococcus aureus. Compound 2d and 2d (Fig-18) showed very potent activity 
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aganist Pseudomonas aeruginosa. While 3a and 3d (Fig-18) exhibited average activity 
against the same organism.                                                                                                                             
                
N.
N
H
R
COC 6H5
N
N
R
SO 2
CH3
          
                             (Fig-18) 
2a R = CH3    3a R = CH3  
                       2d R = C8H7                      3d R = C8H7 
2.18) Raghvendra Dubey et al., 2007 introduced a new method for synthesis of 
benzimidazole derivatives. It involves condensation of substituted ortho phenylene 
diamine with cyanoacetic acid in refluxing ethylene glycol. All of them gave excellent 
yields. Among the all compounds 2a, 2b, 2g (Fig-19) gave more yields. 
  
N
N
R
1
R
R
2
CN
 
          (Fig-19)    
2.19) Leonard et al., 2007 a new series of substituted benzimidazole derivatives and they 
were characterized by IR, NMR and Mass spectral analysis. The synthesized compounds 
were evaluated for anti-inflammatory and anti-bacterial activity. All the compounds (Fig-
20) exhibited significant to moderate anti-inflammatory and anti-bacterial activities. 
 
Compound R R1 R2 
2a H H H 
2b CH3 H H 
2g H H CH3 
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N
N
CH2NR
R1
 
                    (Fig-20) 
2.20) Kazimierczuk et al., 2005 synthesis 2-polyfluroalkyl and 2-nitrobenzyl sufanyl 
benzimidazoles. Compounds were evaluated for their activity against mycobacterium 
strains and compound a and b(Fig-21) showed their MIC values 2 μmol L-1 and 4 μmol  
L-1. 
N
N
H
SR2
R
1
 
                       (Fig-21) 
2.21) Niknam K. et al., 2007 adopted a microwave-assisted method for the synthesis of 2-
substituted benzimidazoles (Fig-22) in the presence of Alumina-Methanesulfonic acid 
(AMA). In addition, some new bis-benzimidazoles prepared from the direct reaction of 
phenylenediamine with di-carboxylic acid under microwave irradiation. This method 
proved to be advantageous over conventional method with respect to that of reaction time 
and yield. 
                  
N
N
H
R
 
      (Fig-22) 
NR R1 
Morpholine 3-NO2 
Piperazine 2-NH2 
Piperidine 3-NO2 
Imidazole 3-NO2 
Diphenyl amine 3-NO2 
Piperazine 3-NO2 
Piperidine 2-NH2 
Compound R1 R2 
A Cl Br 
B C7H6NO2 C4F9 
R= 2-C7H7O R= C6H5 
R= 2-C6H4O2 R= C6H4N 
R= 2-C6H5O R= C6H6N 
R= 2-C6H4Cl R= 4-C6H4Br 
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 2.22) Na Zhao et al., 2005 synthesized a benzimidazoles (Fig-23) under microwave 
irradiation by condensing 1, 2 phenylene diamine with different carboxylic acids without 
catalyst.  
          
N
N
H
R
   
                                (Fig-23) 
 
2.23) Rishipathak D.D. et al., 2007 synthesized various 2-alkyl and 2-aryl substituted 
benzimidazole derivatives (Fig-24) under microwave irradiation. Poly phosphoric acid 
used as a solvent in this method. The synthesized compounds were identified by IR, 
NMR, Mass spectral analysis. This method proved to be advantageous over conventional 
method with respect to reaction time and yield.  
                            
N
N
H
R
(Fig-24) 
 
                                                
 
 
Compound R 
1 C6H5OCH2 
2 2,4(Cl)2C6H3OCH2 
3 CH3 
4 C6H5 
5 CH3 
6 C10H7CH2 
Compound R Compound R 
A 2- CH3 (Acetic Acid) B 2- (CH2C6H5) 
C 2- CH2Cl D 2- CH2CH2CH2CH2CH3 
E C6H5 (Benzamide) F 2- CH3 (Acetamide) 
G 2-( ClC6H4) H 2- C6H5 (Benzoic acid) 
I 2-m-Tolyl  J 2-(NH2C6H4)  
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2.24) Perumal S. et al., 2004 synthesized 2-Aryl-arylmethyl-1H-1, 3-benzimidazoles 
(Fig-25) in the presence of montmorillonite K-10 under Microwave irradiation in the 
absence of solvent. This synthetic protocol was advantageous over the previous methods 
as the reaction performed with an environmentally begin clay catalyst, it provides a good 
yield of product and reaction occurs more rapidly. 
N
N
Ar
-
Ar
-
                            
 (Fig-25) 
2.25) Raghvendra Dubey et al., 2007 synthesized 2-alkyl and 2-Aryl substituted 
benzimidazole derivatives (Fig-26) by both conventional and microwave method in the 
presence of polyphosporicacid. They compared the physical properties of derivatives 
synthesized by both conventional and microwave method and also studied the effect of 
salt form of reactant for completion of the reaction. The microwave method is more 
beneficial, in respect of yield and time than conventional method of synthesis. 
N
N
H
R
 
                 (Fig-26)
Compound R Compound R 
A C6H5 F o-ClC6H4 
B p-MEOC6H4 G 2-Furyl 
C p-MEC6H4 H p-NO2C6H4 
D p-ClC6H4 I o-NO2C6H4 
E o-MEOC6H4 J p-(CH3)2NC6H4 
Code R 
1 H 
2 CH3 
3 C6H6N 
4 C6H4Cl 
  
 
 
 
Aim And plAn of 
the work 
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3. AIM AND PLAN OF WORK 
Aim: 
Continuous increase in bacterial resistance to existing drugs leading to 
development of new drugs with antimicrobial activity against drug resistance 
microorganisms. 
From the literature survey, the benzimidazole derivatives have already been 
assessed for these features of position 4, 6 and 7; however, little work has been directed 
towards the 5- position of benzimidazole. Introduction of a small substituent in to the 2-
and 5- position is characteristic for benzimidazole based anti-helmentics; alternatively, a 
bulky 2-substitution characterizing drugs used in the treatment of peptic ulcer and are 
sometimes referred as proton pump inhibitors; bulky 1- and 2-substituents are found in 
H1-anti-histaminics. It is suggested that one of the requirement for optimal anti-protozoal 
action, is that the substituted benzimidazoles must bear a hydrogen atom at the 1-position 
of benzimidazole ring. (Goel.P.K. et al. 2007) 
Microwave assisted organic synthesis (MAOS) is an acknowledged quick 
alternative and green technology in synthetic organic chemistry, and also it is superior in 
many ways to traditional heating. It can be termed as e-chemistry because it is easy, 
effective, economic and eco-friendly and is believed to be a step towards green 
chemistry. Many organic reaction proceeds much faster and with higher yields under 
microwave irradiation compared to conventional heating. 
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So, in the present communication, we decided to synthesize 2-substituted 
benzimidazole derivatives by both conventional and microwave method and compare the 
yield. Further the study will extended to introduce substitution on 5th position, and to 
screen the newly synthesized compounds for their anti-bacterial and anti-fungal activity. 
PLAN OF THE WORK: 
 Synthesis of 2-subsituted benzimidazole derivatives by conventional Method. 
  Synthesis of 2-subsituted benzimidazole derivatives by Microwave Method. 
 Synthesis of 5-nitro 2-subsituted benzimidazole derivatives. 
 Synthesis of 5-amino 2-subsituted benzimidazole derivatives. 
 Determination of physical properties of 5-amino 2-subsituted benzimidazole 
derivatives. 
  Spectral characterization of 5-amino 2-subsituted benzimidazole derivatives  
  Evaluation of anti-bacterial and anti-fungal activity of 5-amino-2-subsituted 
benzimidazole derivatives. 
  
 
 
EXPERIMENTAL 
MATERIALS AND 
INSTRUMENTS 
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4. EXPERIMENTAL 
4.1. Materials and Instruments: 
 Melting points were determined in open capillary tubes on melting point 
apparatus (sunbim, Guna enterprises) and are uncorrected. Spectral analyses were 
performed in the Sophisticated Analytical Instrumentation Facility (SAIF), Indian 
Institute of Technology, Madras, using 1H NMR (Bruker-NMR 500 mHZ) spectrometer 
and Mass (JEOL GC mate) spectrometer. FT-IR (Perkin-Elmer) was performed in Ideal 
Analytical Research Institute Puduchery, and UV spectra were recorded by using Double 
beam UV Spectrometer SHIMADZU 1700 at Adhiparasakthi College of Pharmacy, 
Melmaruvathur. 
In 1H NMR, chemical shifts were reported in δ values MeOD and DMSO – d6 as 
a solvent and tetramethylsilane as internal standard with number of protons, multiplicities 
(s-singlet, d-doublet, t-triplet, m-multiplet.) in the solvent indicated and IR spectra was 
recorded in KBr pellets. 
All the chemicals and reagents and were commercially available (Rankem, SD 
fine, Loba and Fluka) and of synthetic grade. Glasswares were as oven or flame dried for 
moisture sensitive reactions. When necessary, solvents and reagents were dried prior to 
use. Solution or extracts in organic solvents were dried over anhydrous sodium sulphate 
or fused calcium chloride before evaporation to under vacuum using rotary evaporator. 
Analytical samples were dried in vaccum and were free of significant impurities on TLC. 
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Two gram negative bacterial organisms (Proteus vulgaris NCTC 4635, Klesibella 
pneumonia ATCC 29655) and gram positive bacterial organisms (Bacillus cereus NL98, 
Enterococcus faecium ATCC 29212) and two fungi strains (Aspergillus niger and 
Aspergillus  fumigatus) were collected from Microbial Resources Division, Kings 
Institute of Preventive Medicine, Guindy, Chennai.   
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4.2 Methodology: 
Monitoring of Synthetic Reaction Procedures: 
 Synthetic procedures were employed for synthesis of compounds SY1 to SY15 
and the completion of reactions were monitored by Thin Layer Chromatography (TLC). 
Silica gel G is used as a adsorbent, the plates were activated by heating at 110° C for one 
hour. Methanol: water, Methanol: Chloroform mixtures (9:1, 8:2, 7:3) were used as a 
Mobile phase. The plates were visualized by UV light, iodine chamber. 
Purification Techniques: 
Recrystallization: The crude products were recrystallized by charcoal treatment 
with appropriate solvent. Single solvent was used wherever possible and solvent mixtures 
were not used anywhere.  
Authentication of Chemical Structures and Purity of Compounds: 
Chemical structure of synthesized compounds and their purity were identified by 
thin layer chromatography, UV-visible spectrometer, melting point and various spectral 
techniques including Fourier Transform Infra Red Spectroscopy, Nuclear Magnetic 
Resonance Spectroscopy, Mass Spectroscopy and Ultra Violet Spectrophotometry. 
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4.3. Synthesis of compounds: 
4.3.1. Synthesis of 1 H-benzimidazol-2-yl methane thiol: (SY1) 
a. Conventional method: 
O-phenylene diamine 27 g (0.25 M) and thioglycollic acid 31.28 g (0.34 M) was 
heated on a water bath at 100o C for 6-8 h. The completion of reaction was monitored 
by TLC. After completion of reaction, the reaction mixture was cooled and basified to 
a pH of 7-8 by using of 10% sodium hydroxide solution. The crude benzimidazole was 
filtered at the pump, washed with ice cold water. The crude product was dissolved in 
400 ml of boiling water and 2 g of decolorizing carbon was added, digested for 15 
min. The solution was filtered while hot, cooled the filtrate to about 10o C. The pure 
product was filtered, washed with 25 ml of cold water and dried at 100o C. (Vogel’s 
2006,  Ahuluwalia  et al., 2000) 
N
N
H
CH2SH
NH2
NH2
+ HOOCCH 2SH
Reflux 6 to 8 h
O-phenylene diamine thioglycollic acid 1 H-benzimidazol-2-yl methane thiol 1 H-benzimidazol-2-yl methane thiol
 
Scheme- 1.a: Synthesis of 1 H-benzimidazol-2-yl methane thiol 
b. Microwave method: 
O-phenylene diamine 1.08 g (0.01 M), thioglycollic acid 0.92 g (0.01 M) and poly 
phosphoric acid 10 g was properly mixed with glass rod in a beaker. The mixture was 
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irradiated in the microwave oven for 2 min 20 sec at 600 W. The completion of reaction 
was monitored by TLC, after irradiation the mixture was poured into ice cold water and 
then slowly neutralized with sodium hydroxide to pH 8. The precipitate was collected by 
filtration, dried and recrystallized from hot water.  
(Rishipathak et al., 2007, Perumal et al., 2004) 
N
N
H
CH2SH
NH2
NH2
+ HOOCCH 2SH
O-phenylene diamine thioglycollic acid 1 H-benzimidazol-2-yl methane thiol 1 H-benzimidazol-2-yl methane thiol
Micro wave
PPA
600 W
2 min 20 sec
 
             Scheme- 1.b: Synthesis of 1 H-benzimidazol-2-yl methane thiol 
4.3.2. Synthesis of 2-(propan-2-yl)-1H-benzimidazole: (SY2) 
a. Conventional method: 
O-phenylene diamine 27 g (0.25 M) and isobutyric acid 29.92 g (0.34 M) was 
heated on a water bath at 100o C for 6-8 h. The completion of reaction was monitored by 
TLC. After completion of reaction, the reaction mixture was cooled and basified to a pH 
of 7-8 by using of 10% sodium hydroxide solution. The crude benzimidazole was 
filtered at the pump, washed with ice cold water. The crude product was dissolved in 
400 ml of boiling water and  2 g of decolorizing carbon was added, digested for 15 min. 
The solution was filtered while hot, cooled the filtrate to about 10o C. The pure product 
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was filtered, washed with 25 ml of cold water and dried at 100o C. (Vogel’s 2006,  
Ahuluwalia  et al., 2000) 
NH2
NH2
+ CH3
CH3
COOH
N
N
H
CH3
CH3
2-(propan-2-yl)-1H-benzimidazoleO-phenylene diamine isobutyric acid
Reflux 6 to 8 h
 
Scheme- 2.a: Synthesis of 2-(propan-2-yl)-1H-benzimidazole 
b. Microwave method: 
O-phenylene diamine 1.08 g (0.01 M), isobutyric acid 0.88 g (0.01 M) and poly 
phosphoric acid 10 g was properly mixed with glass rod in a beaker. The mixture was 
irradiated in the microwave oven for 1 min 30 sec at 600 W. The completion of reaction 
was monitored by TLC, after irradiation the mixture was poured into ice cold water and 
then slowly neutralized with sodium hydroxide to pH 8. The precipitate was collected by 
filtration, dried and recrystallized from hot water.  
(Rishipathak et al., 2007, Perumal et al., 2004) 
NH2
NH2
+ CH3
CH3
COOH
N
N
H
CH3
CH3
2-(propan-2-yl)-1H-benzimidazoleO-phenylene diamine isobutyric acid
Micro wave
PPA
600W
1 min 30 sec
 
Scheme- 2.b: Synthesis of 2-(propan-2-yl)-1H-benzimidazole 
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4.3.3. Synthesis of 2-butyl-1H-benzimidazole: (SY3) 
a. Conventional method: 
O-phenylene diamine 27 g (0.25 M) and valeric acid 34.68 g (0.34 M) was heated 
on a water bath at 100o C for 6-8 h. The completion of reaction was monitored by TLC. 
After completion of reaction, the reaction mixture was cooled and basified to a pH of 7-
8 by using of 10% sodium hydroxide solution. The crude benzimidazole was filtered at 
the pump, washed with ice cold water. The crude product was dissolved in 400 ml of 
boiling water and  2 g of decolorizing carbon was added, digested for 15 min. The 
solution was filtered while hot, cooled the filtrate to about 10o C. The pure product was 
filtered, washed with 25 ml of cold water and dried at 100o C. (Vogel’s 2006,  
Ahuluwalia et al., 2000)   
NH2
NH2
+ CH3CH2CH2CH2COOH
N
N
H
CH2CH2CH2CH3
valeric acid 2-butyl-1H-benzimidazoleO-phenylene diamine
Reflux 6 to 8 h
 
Scheme- 3.a: Synthesis of 2-butyl-1H-benzimidazole 
b. Microwave method: 
O-phenylene diamine 1.08 g (0.01 M), valeric acid 1.02 g (0.01 M) and poly 
phosphoric acid 10 g was properly mixed with glass rod in a beaker. The mixture was 
irradiated in the microwave oven for 1 min 15 sec at 600 W. The completion of reaction 
was monitored by TLC, after irradiation the mixture was poured into ice cold water and 
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then slowly neutralized with sodium hydroxide to pH 8. The precipitate was collected by 
filtration, dried and recrystallized from hot water. 
(Rishipathak et al., 2007, Perumal et al., 2004) 
NH2
NH2
+ CH3CH2CH2CH2COOH
N
N
H
CH2CH2CH2CH3
valeric acid 2-butyl-1H-benzimidazoleO-phenylene diamine
Micro wave
PPA
600 W
1 min 15 sec
 
Scheme- 3.a: Synthesis of 2-butyl-1H-benzimidazole 
4.3.4. Synthesis of (1H-benzimidazol-2-yl) aniline: (SY4) 
a. Conventional method: 
A mixture of O-phenylene diamine 3.8 g (34 mM) and 4-amino benzoic acid 4.5 g    
(33 mM) were stirred in a syrupy O-phosphoric acid (45 ml) at 200º C for 2 h. The 
reaction mixture was cooled and poured on to the crushed ice. The bulky white 
precipitate obtained was stirred in cold water (400 ml) and sodium hydroxide solution     
(5 M) was added until the pH 7. The resulting solid was filtered and recrystallized from 
methanol. (Sreena et al., 2009) 
NH2
NH2
+ NH2HOOC
N
N
H
NH2
200
o
 C
2 h
O-phenylene diamine 4-(1H-benzimidazol-2-yl) aniline4-amino benzoic acid
 
       Scheme- 4.a: Synthesis of (1H-benzimidazol-2-yl) aniline 
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b. Microwave method: 
O-phenylene diamine 1.08 g (0.01 M), 4-amino benzoic acid 1.37 g (0.01 M) and 
poly phosphoric acid 10 g was properly mixed with glass rod in a beaker. The mixture 
was irradiated in the microwave oven for 6 min 30 sec at 600 W. The completion of 
reaction was monitored by TLC, after irradiation the mixture was poured into ice cold 
water and then slowly neutralized with sodium hydroxide to pH 8. The precipitate was 
collected by filtration, dried and recrystallized from methanol. 
(Rishipathak et al., 2007, Perumal et al., 2004) 
NH2
NH2
+ NH2HOOC
N
N
H
NH2
4-aminobenzoic acid 4-(1H-benzimidazol-2-yl)aniline
Microwave
PPA
O-phenylene diamine
600 W
6 min 30 sec
 
        Scheme- 4.b: Synthesis of (1H-benzimidazol-2-yl) aniline 
4.3.5. Synthesis of 2-(4-nitrophenyl)-1H-benzimidazole: (SY5) 
a. Conventional method: 
O-phenylene diamine 1.08 g (0.01 M) and 4-nitro benzoic acid 1.69 g (0.01 M) in       
20 ml acetic acid was refluxed for 4 h. The precipitate obtained after cooling was 
recrystallized from ethanol. (Mohamed al messmary et al., 2010) 
NH2
NH2
+ NO2HOOC
N
N
H
NO2
2-(4-nitrophenyl)-1H-benzimidazole
Reflux 4h
O-phenylene diamine 4-nitro benzoic acid
 
   Scheme- 5.a: Synthesis of 2-(4-nitrophenyl)-1H-benzimidazole 
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b. Microwave method: 
O-phenylene diamine 1.08 g (0.01 M), 4-nitro benzoic acid 1.69 g (0.01 M) and 
poly phosphoric acid 10 g was properly mixed with glass rod in a beaker. The mixture 
was irradiated in the microwave oven for 8 min 30 sec at 600 W. The completion of 
reaction was monitored by TLC, after irradiation the mixture was poured into ice cold 
water and then slowly neutralized with sodium hydroxide to pH 8. The precipitate was 
collected by filtration, dried and recrystallized from ethanol. 
(Rishipathak et al., 2007, Perumal et al., 2004) 
NH2
NH2
+ NO2HOOC
N
N
H
NO2
4-nitrobenzoic acid 2-(4-nitrophenyl)-1H-benzimidazole
Microwave
PPA
O-phenylene diamine
600 W
8 min 30 sec
 
       Scheme- 5.b: Synthesis of 2-(4-nitrophenyl)-1H-benzimidazole 
4.3.6. Synthesis of (5-nitro-1H-benzimidazol-2-yl) methane thiol: (SY6) 
Conc. HNO3 (7.5 ml) was placed in 3-necked round bottom flask fitted with a 
mechanical stirrer.  The flask was immersed in ice cold water and added slowly Conc. 
H2SO4 (7.5 ml) down the condenser with slow stirring. After the addition, 1H-
benzimidazol-2yl-methane thiol 4.59 g (0.028 M) was added in a portion over a period of 
1 h at such a rate that the temperature did not exceed 35º C. After continuous stirring for 
12 h, the reaction mixture was poured very slowly over crushed ice with vigorous 
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stirring.  The formed product was filtered, washed with cold water and recrystallized 
from ethanol. (Jitender Singh et al., 2010) 
N
N
H
CH2SH
N
N
H
CH2SH
O2N
HNO3/H2SO4
12 h Stirring
1H-benzimidazol-2-ylmethane thiol (5-nitro-1H-benzimidazol-2-yl) methane thiol
35
o
 C
 
                     Scheme- 6: Synthesis of (5-nitro-1H-benzimidazol-2-yl) methane thiol 
4.3.7. Synthesis of 5-nitro 2-(propan-2-yl)-1H-benzimidazole: (SY7) 
Conc. HNO3 (7.5 ml) was placed in 3-necked round bottom flask fitted with a 
mechanical stirrer.  The flask was immersed in ice cold water and added slowly Conc. 
H2SO4 (7.5 ml) down the condenser with slow stirring. After the addition, 2-(propan-2-
yl)-1H-benzimidazole 4.48 g (0.028 M) was added in a portion over a period of 1 h at 
such a rate that the temperature did not exceed 35º C. After continuous stirring for 12 h, 
the reaction mixture was poured very slowly over crushed ice with vigorous stirring.  The 
formed product was filtered, washed with cold water and recrystallized from ethanol. 
(Jitender Singh et al., 2010) 
N
N
H
CH3
CH3
HNO3/H2SO4
12h Stirring
N
N
H
CH3
CH3
O2N
2-(propan-2-yl)-1H-benzimidazole 5-nitro-2-(propan-2-yl)-1H-benzimidazole
35o C
 
    Scheme- 7: Synthesis of 5-nitro 2-(propan-2-yl)-1H-benzimidazole 
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4.3.8. Synthesis of 5-nitro 2-butyl-1H-benzimidazole: (SY8) 
Conc. HNO3 (7.5 ml) was placed in 3-necked round bottom flask fitted with a 
mechanical stirrer.  The flask was immersed in ice cold water and added slowly Conc. 
H2SO4 (7.5 ml) down the condenser with slow stirring. After the addition, 2-butyl-1H-
benzimidazole 4.87 g (0.028 M) was added in a portion over a period of 1 h at such a rate 
that the temperature did not exceed 35º C. After continuous stirring for 12 h, the reaction 
mixture was poured very slowly over crushed ice with vigorous stirring.  The formed 
product was filtered, washed with cold water and recrystallized from ethanol. (Jitender 
Singh et al., 2010) 
N
N
H
CH2CH2CH2CH3
N
N
H
CH2CH2CH2CH3
O2N
HNO3/H2SO4
12 h Stiring
2-butyl-1H-benzimidazole 5-nitro 2-butyl-1H-benzimidazole
35o C
 
                         Scheme- 8: Synthesis of 5-nitro 2-butyl-1H-benzimidazole 
4.3.9. Synthesis of 4-(5-nitro-1H-benzimidazol-2-yl) aniline: (SY9) 
Conc. HNO3 (7.5 ml) was placed in 3-necked round bottom flask fitted with a 
mechanical stirrer.  The flask was immersed in ice cold water and added slowly Conc. 
H2SO4 (7.5 ml) down the condenser with slow stirring. After the addition, (1H-
benzimidazol-2-yl) aniline 5.85 g (0.028 M) was added in a portion over a period of 1 h 
at such a rate that the temperature did not exceed 35º C. After continuous stirring for 12 
h, the reaction mixture was poured very slowly over crushed ice with vigorous stirring.  
The formed product was filtered, washed with cold water and recrystallized from ethanol. 
(Jitender Singh et al., 2010) 
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N
N
H
NH2
O2N
HNO3/H2SO4
12 h Stiring
4-(1H-benzimidazol-2-yl) aniline 4-(5-nitro-1H-benzimidazol-2-yl) aniline
N
N
H
NH2
35
o
 C
 
Scheme- 9: Synthesis of4-(5-nitro-1H-benzimidazol-2-yl) aniline 
4.3.10. Synthesis of 5-nitro 2-(4-nitrophenyl)-1H-benzimidazole: (SY10) 
Conc. HNO3 (7.5 ml) was placed in 3-necked round bottom flask fitted with a 
mechanical stirrer.  The flask was immersed in ice cold water and added slowly Conc. 
H2SO4 (7.5 ml) down the condenser with slow stirring. After the addition, 2-(4-
nitrophenyl)-1H-benzimidazole 6.69 g (0.028 M) was added in a portion over a period of 
1 h at such a rate that the temperature did not exceed 35º C. After continuous stirring for 
12 h, the reaction mixture was poured very slowly over crushed ice with vigorous 
stirring.  The formed product was filtered, washed with cold water and recrystallized 
from ethanol. (Jitender Singh et al., 2010) 
N
N
H
NO2
2-(4-nitrophenyl)-1H-benzimidazole
N
N
H
NO2
O2N
HNO3/H2SO4
12 h Stiring
5-nitro 2-(4-nitrophenyl)-1H-benzimidazole
35
o
 C
 
Scheme- 10: Synthesis of 5-nitro 2-(4-nitrophenyl)-1H-benzimidazole 
4.3.11. Synthesis of (5-amino-1H-benzimidazol-2-yl) methane thiol: (SY11) 
A solution of 0.5 g of (5-nitro-1H-benzimidazol-2-yl) methane thiol in 15 ml of 
rectified spirit was taken in round bottom flask. To this, 5 ml of 20 % sodium hydroxide 
and 2.5 g of zinc dust powder was added. The reaction mixture was refluxed until colour 
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of the solution changed from deep red to colourless (about 4.5 h), the hot mixture was 
filtered. The zinc residue was return to the flask and extracted with 10 ml of hot rectified 
sprit for two times. The extracts were combined; the solvent was removed under vacuum, 
yielded the brown solid and recrystallized from methanol. (Raju et al., 2009) 
N
N
H
CH2SH
O2N N
N
H
CH2SH
NH2Zn/NaOH
(5-nitro-1H-benzimidazol-2-yl)methanethiol (5-amino-1H-benzimidazol-2-yl)methanethiol
Reflux 4.5 h
< 
Scheme- 11: Synthesis of (5-amino-1H-benzimidazol-2-yl) methanethiol 
4.3.12. Synthesis of 5-amino 2-(propan-2-yl)-1H-benzimidazole: (SY12)  
A solution of 0.5 g of 5-nitro-2-(propan-2-yl)-1H-benzimidazole in 15 ml of 
rectified spirit was taken in round bottom flask. To this, 5 ml of 20 % sodium hydroxide 
and 2.5 g of zinc dust powder was added. The reaction mixture was refluxed until colour 
of the solution changed from deep red to colourless (about 4.5 h), the hot mixture was 
filtered. The zinc residue was return to the flask and extracted with 10 ml of hot rectified 
sprit for two times. The extracts were combined; the solvent was removed under vacuum, 
yielded the brown solid and recrystallized from methanol. (Raju et al., 2009) 
 
N
N
H
CH3
CH3
O2N
N
N
H
CH3
CH3
NH2Zn/NaOH
5-nitro-2-(propan-2-yl)-1H-benzimidazole
Reflux 4.5 h
5-amino 2-(propan-2-yl)-1H-benzimidazole
 
Scheme- 12: Synthesis of 5-amino 2-(propan-2-yl)-1H-benzimidazole 
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4.3.13. Synthesis of 5-amino 2-butyl-1H-benzimidazole: (SY13)  
A solution of 0.5 g of 5-nitro 2-butyl-1H-benzimidazole in 15 ml of rectified spirit 
was taken in round bottom flask. To this, 5 ml of 20 % sodium hydroxide and 2.5 g of 
zinc dust powder was added. The reaction mixture was refluxed until colour of the 
solution changed from deep red to colourless (about 4.5 h), the hot mixture was filtered. 
The zinc residue was return to the flask and extracted with 10 ml of hot rectified sprit for 
two times. The extracts were combined; the solvent was removed under vacuum, yielded 
the brown solid and recrystallized from methanol. (Raju et al., 2009) 
 
N
N
H
CH2CH2CH2CH3
O2N N
N
H
CH2CH2CH2CH3
NH2Zn/NaOH
Reflux 4.5 h
5-nitro 2-butyl-1H-benzimidazole 5-amino 2-butyl-1H-benzimidazole
 
                 Scheme- 13: Synthesis of 5-amino 2-butyl-1H-benzimidazole 
4.3.14. Synthesis of 5-amino 2-(4-aminophenyl)-1H-benzimidazole: (SY14) 
A solution of 0.5 g of 4-(5-nitro-1H-benzimidazol-2-yl) aniline in 15 ml of 
rectified spirit was taken in round bottom flask. To this, 5 ml of 20 % sodium hydroxide 
and 2.5 g of zinc dust powder was added. The reaction mixture was refluxed until colour 
of the solution changed from deep red to colourless (about 4.5 h), the hot mixture was 
filtered. The zinc residue was return to the flask and extracted with 10 ml of hot rectified 
sprit for two times. The extracts were combined; the solvent was removed under vacuum, 
yielded the brown solid and recrystallized from methanol. (Raju et al., 2009) 
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N
N
H
NH2
O2N N
N
H
NH2
NH2Zn/NaOH
4-(5-nitro-1H-benzimidazol-2-yl)aniline
Reflux 4.5 h
5-amino 2-(4-aminophenyl)-1H-benzimidazole
 
                 Scheme- 14: Synthesis of 5-amino 2-(4-aminophenyl)-1H-benzimidazole 
4.3.15. Synthesis of 5-amino 2-(4-nitrophenyl)-1H-benzimidazole: (SY15)  
A solution of 0.5 g of 5-nitro 2-(4-nitrophenyl)-1H-benzimidazole in 15 ml of 
rectified spirit was taken in round bottom flask. To this, 5 ml of 20% sodium hydroxide 
and 2.5 g of zinc dust powder was added. The reaction mixture was refluxed until colour 
of the solution changed from deep red to colourless (about 4.5 h), the hot mixture was 
filtered. The zinc residue was return to the flask and extracted with 10 ml of hot rectified 
sprit for two times. The extracts were combined; the solvent was removed under vacuum, 
yielded the brown solid and recrystallized from methanol. (Raju et al., 2009) 
N
N
H
NO2
O2N
2-(4-nitrophenyl)-1H-benzimidazole
N
N
H
NO2
NH2
Zn/NaOH
Reflux 4.5 h
5-amino 2-(4-nitrophenyl)-1H-benzimidazole
 
Scheme- 15: Synthesis of 5-amino 2-(4-nitrophenyl)-1H-benzimidazole 
  
 
 
 
BIOLOGICAL 
SCREENING 
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5. BIOLOGICAL SCREENING 
5.1. Evaluation of in vitro anti-bacterial activity: 
 The synthesized compounds (SY11-SY15) were tested for anti-bacterial activity by 
disc diffusion method.  They were dissolved in DMSO and sterilized by filtering through 
0.45 μm millipore filter. A final inoculum of 100 µl suspension containing 108 CFU/ ml 
of each bacterium was used. Nutrient agar medium was prepared and sterilized by an 
autoclave (121º C and 15 lbs for 20 min) and transferred to previously sterilized 
petridishes (9 cm in diameter). After solidification, petriplates were inoculated with gram 
negative bacterial organisms Proteus vulgaris NCTC 4635, Klesibella pneumonia ATCC 
29655 and gram positive bacterial organisms Bacillus cereus NL98, Enterococcus 
faecium ATCC 29212 in sterile nutrient agar medium at 45o C under aseptic condition. 
Sterile whatmann filter paper discs (previously sterilized in U.V. lamp) were 
impregnated with synthesized compounds at a concentration of 25, 100 µg/disc were 
placed in the organism-impregnated petri plates under sterile condition. The plates were 
left for 30 min to allow the diffusion of compounds at room temperature. Antibiotic disc 
of ciprofloxacin (100 µg /disc) was used as positive control, while DMSO used as 
negative control. Then the plates were incubated for 24 h at 37 ± 1o C. The zone of 
inhibition (Table-3) was calculated by measuring the minimum dimension of the zone of 
no microbial growth around the each disc. 
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5.2. Evaluation of in vitro anti-fungal activity: 
 The synthesized compounds (SY11-SY15) were tested for anti-fungal activity by 
disc diffusion method.  They were dissolved in DMSO and sterilized by filtering through 
0.45 μm millipore filter. A final inoculum of 100 µl suspension containing 108 CFU/ ml 
of each fungus was used.  Sabouraud dextrose agar medium was prepared and sterilized 
by an autoclave     (121º C and 15 lbs for 20 min) and transferred to previously sterilized 
petridishes (9 cm in diameter). After solidification, petriplates were inoculated with 
fungal organism Aspergillus niger and Aspergillus fumigatus in sterile sabouraud 
dextrose agar medium at 45o C in aseptic condition. Sterile whatmann filter paper discs 
(previously sterilized in U.V. lamp) were impregnated with synthesized compounds at a 
concentration of 25, 100 µg/disc were placed in the organism-impregnated petri plates 
under sterile condition. The plates were left for 30 min to allow the diffusion of 
compounds at room temperature. Antibiotic disc of ketaconazole (100 µg /disc) were 
used as positive control, while DMSO used as negative control. Then the plates were 
incubated for 48 h at 37±1o C for antifungal activity. The zone of inhibition (Table-4) 
was calculated by measuring the minimum dimension of the zone of no microbial growth 
around the each disc. 
  
 
 
RESULTS AND 
DISCUSSION 
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6. RESULTS AND DISCUSSION 
6.1. Synthetic Scheme 
There are several methods reported for synthesis of 2-substituted benzimidazole 
derivatives. Mainly two methods are widely employed, which are coupling of                
O-phenylene diamine with different substituted organic acid in the presence of strong 
acidic medium (it also done through microwave irradiation) and the coupling of            
O-phenylene diamine with different substituted aldehydes. 
 
NH2
NH2
+ R COOH
Reflux 6 - 8 h N
N
H
R
O-phenylene diamine Substituted acids 2-Substituted benzimidazoles
(SY 1 - SY 5)
a. Conventional method
NH2
NH2
+ R COOH
Micro wave
N
N
H
R
O-phenylene diamine Substituted acids 2-Substituted benzimidazoles
(SY 1 - SY 5)
b. Micro wave method
PPA
600 W
- 2H2O
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N
N
H
R
HNO3/H2SO4
N
N
H
R
O2N
Stirred for 12 h
N
N
H
R
O2N
Step 3:-
N
N
H
R
NH2
Zn/NaoH
2-Substituted benzimidazoles
(SY 6-SY 10)
Reflux 4.5 h
5-Nitro 2-substituted benzimidazoles
5-Nitro 2-substituted benzimidazoles 5-Amino 2-substituted benzimidazoles
(SY 11-SY 15)
Step 2:-
35o C
 
 
 
 
 
 
Scheme-16: General synthetic route for 2, 5 di substituted benzimidazole derivatives 
 Various oxidative and catalytic reagents such as sulfamic acid, DDQ, air, Oxone, 
FeCl3·6H2O, In (OTf)3, Yb (OTf)3, 1 Sc (OTf)3, KHSO4, IL, have been employed. 
Because of the availability of a vast number of aldehydes, the condensation of phenylene 
Code R 
SY 1, SY6,  SY 11 CH2SH 
SY 2,  SY 7,  SY 12 CH(CH3)2 
SY 3,  SY 8,  SY 13 CH2CH2CH2CH3 
SY 4,  SY 9,  SY 14 C6H6N 
SY 5,  SY 10,  SY 15 C6H4NO2 
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diamines and aldehydes has been extensively used. While many published methods are 
effective, some of these methods suffer from one or more disadvantages such as high 
reaction temperature, prolonged reaction time, and toxic solvents etc. Long reaction 
times for this reaction have been mitigated by the use of microwave heating, both with 
and without poly phosphoric acid. (Hanxiangming et al., 2007). 
Compounds in which the aromatic (or) aliphatic ring is directly attached to the 
second position of the benzimidazole ring were substituted by our scheme. In this method 
benzimidazole were synthesized from O-phenylene diamine by reaction with mono 
aliphatic or aromatic carboxylic acids. The reaction was neutralized with sodium 
hydroxide solution and the crude benzimidazoles (SY1-SY5) were isolated by filtration.                
(Goel. P. K, et al., 2007). 
             SY1-SY5 was then subjected to nitration using a mixture (1:1) of Conc. HNO3 
and Conc. H2SO4. Earlier studies with benzimidazolinone suggest that it acetic 
anhydride, nitration product generated depends upon the temperature employed. At     
30° C specifically, the 5-nitro derivative was obtained whereas at 70° C, 5, 6-dinitro 
product was formed. On the basis, we carried out nitration of SY1-SY5 under controlled 
temperature condition at 35° C resulting in the exclusive 5-nitro benzimidazole derivative 
which was confirmed by spectral analysis. 
 SY6-SY10 was then subjected to reduction using a mixture of zinc and sodium 
hydroxide. The resulting product was obtained by heating the reaction mixture up to 4.5 
h. Finally the compounds were confirmed by spectral analysis. (jag mohan, 2006) 
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N
H
H
NH2
:
+ R
O
OH
N
H
NH2
OH
OH
R
-H2O
 
N
N
H
H
R
OH
:
N
N
H
R - H2O
Scheme-17: Mechanism of 2-substituted benzimidazoles 
The sulphuric acid convert’s nitric acid into highly reactive nitronium ion (NO2+) 
which is an electrophile and attacks the position of highest electron density in the 
molecule to form a resonance stabilized intermediate which then eliminates a proton to 
form nitrated derivative. (Vishnoi N.K, 1996) 
H2SO4 + HNO3 (H2NO3)
+ + HSO4
-
(H2NO3)
+ H2O + NO2
+
 
H.
+ + HSO4
-
H2SO4 
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N
N
H
R
H
+ NO2
+ N
N
H
R
H
O2N
+
.H+-
2-Substituted benzimidazole nitroniun ion Resonance stabilized intermediate
                                                                             
N
N
H
R
O2N
5-nitro-2-substituted benzimidazole       
Scheme-18: Nitration mechanism of 2-substituted benzimidazole 
N
N
H
N
+
O
-
O
R
2 e- + 2 H+
- H2O
N
N
H
N
O
R
Nitro compound Nitroso compound  
N
N
H
N
O
R
Nitroso compound
N
N
H
NH
OH
R
N - substituted hydroxylamine
2 e- + 2 H+
N
N
H
NH2
R
Primary amine
2 e- + 2 H+ - H2O
 
Scheme-19: Reduction mechanism of 5 nitro 2-substituted benzimidazole 
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6.2. Interpretation of Spectral data of synthesized compounds (SY1-SY15): 
6.2.1 Spectral analysis of 1 H-benzimidazol-2-yl methane thiol 
UV: (Fig-27) 
λmax (MeOH)                                280.5 (ε max 0.9941) 
λmax (MeOH)                                242.5 (ε max 0.8943) 
IR (KBr): (Fig-28) 
Wave Number (Cm-1)                                      Assignment 
3369.99      N-H stretching 
3100.50     Aromatic C-H stretching 
3058.43      Aromatic C-H stretching 
2539.91      S-H stretching 
1661.54     Aromatic C=C stertching 
1556.06      C=N stretching 
1484.89      C-H bending(scissoring) 
1361.16      C-H bending (wagging) 
1271.0       C-N stretching 
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736.66       C-H bending (rocking) 
670.44       C-S stretching 
 NMR (MeOD): (Fig-29) 
N
N
H
SH
7.70
7.70
7.26
7.26
5.0
3.82
1.5
 
(4 aromatic protons, 2 aliphatic protons, 1 proton on nitrogen and 1 proton on sulphur) 
         δ                                                                    Assignment 
      7.70                                                       (2H, m, Ar-H- C4&C7) 
      7.26                                                       (2H, m, Ar-H- C5&C6) 
      5.0                                                         (1H, s, broad, NH) 
      3.82        (2H, s, CH2) 
      1.5                                 (1H, s, SH) 
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Fig27:  UV Spectrum of compound SY1 
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Fig-28:  IR Spectrum of compound SY1 
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Fig-29: 1H-NMR Spectra of the compound SY1 
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6.2.2. Spectral analysis of 2-(propan-2-yl)-1H-benzimidazole:  
UV: (Fig-30) 
λmax (MeOH)                                 275.5 (ε max 0.0287) 
λmax (MeOH)                                 210.0 ((ε max 1.6715) 
IR (KBr): (Fig-31) 
Wave Number (Cm-1)                                                 Assignment 
3363.57      N-H stretching 
3032.10      Aromatic C-H stretching 
2667.83      C-H stretching 
1632.61      C=C stretching 
1591.92      C=N stretching 
1320.5       C-H bending (gem-dimethyl) 
1272.31      C-N stretching 
1114.79      C-C stretching 
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NMR (MeOD): (Fig-32) 
N
N
H
7.70
7.70
7.26
7.26
5.0
3.12
1.29
1.29
 
(4 aromatic protons, 7 aliphatic protons, and 1 proton on nitrogen) 
       δ                                                                  Assignment 
      7.70                                                        (2H, m, Ar-H- C4&C7) 
     7.26                                                       (2H, m, Ar-H- C5&C6) 
     5.0                                                         (1H, s, broad, NH) 
     3.12       (1H, m, CH of iso propyl) 
     1.29       (6H, d, 2CH3 of iso propyl) 
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(Fig-30: UV Spectrum of compound SY2) 
53 
 
 
 
 
  
                   
Fig-31:   IR Spectrum of compound SY2 
54 
 
 
 
 
  
            
Fig-32:  1H-NMR Spectrum of the compound SY2 
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6.2.3. Spectral analysis of 2-butyl-1H-benzimidazole: 
UV: (Fig-33) 
λmax (MeOH)                                  293.5 (ε max 0.2321) 
λmax (MeOH)       238.0 (ε max  0.4681) 
IR (KBr): (Fig-34) 
Wave Number (Cm-1)                                                             Assignment 
3385.62       C-H stretching 
3192.57       C-H stretching 
3288.94       N-H stretching 
3032.75       Aromatic C-H stretching 
1632.86       C=C stretching 
1590.16       C=N stretching 
1458.17       C-H bending (scissoring) 
1272.45       C-N stretching 
1031.54       C-C stretching 
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NMR (MeOD): (Fig-35) 
N
N
H
7.70
7.70
7.26
7.26
5.0
2.55
1.62
1.33
0.96  
(4 aromatic protons, 9 aliphatic protons, and 1 proton on nitrogen) 
    δ                                                                Assignment 
  7.70                                                    (2H, m, Ar-H- C4&C7) 
  7.26                                                    (2H, m, Ar-H- C5&C6) 
  5.0                                                      (1H, s, broad, NH) 
  2.55             (2H, t, CH2)    
  1.62             (2H, m, CH2) 
  1.33             (2H, m, CH2) 
  0.96              (3H, t, methyl, C11) 
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Fig-33: UV Spectrum of compound SY3 
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Fig-34: IR Spectrum of compound SY3 
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 Fig-35: 1H-NMR Spectrumof the Compound SY3 
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6.2.4. Spectral analysis of (1H-benzimidazol-2-yl) aniline: 
UV: (Fig-36) 
λmax (MeOH)                                294.5 (ε max 0.4906) 
IR (KBr): (Fig-37) 
Wave Number (Cm-1)                                        Assignment 
3514.74       N-H asymmetrical stretching (primary amine) 
3463.63       N-H stretching (primary amine) 
3358.60       N-H stretching (secondary amine) 
2968.78                  aromatic C-H stretching 
1621.12                  N-H bending 
1274.47       C-N stretching 
1181.99       In plane bending of aromatics 
836.02        Out of plane bending of aromatics 
697.94        Out of plane bending (substituted benzene) 
 NMR (MeOD): (Fig-38) 
N
N
H
NH2
7.70
7.70
7.26
7.26
5.0
6.52
6.52
7.23
7.23
4.0
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(8 aromatic protons and 3 protons on nitrogen) 
      δ                                                       Assignment 
  7.70                                                   (2H, m, Ar-H- C4&C7) 
  7.23-7.26           (4H, m, Ar-H- C5,C6&C2´,C6´ ) 
  6.52            (2H, m, Ar–H- C3´&C5´) 
  5.0                                                     (1H, s, broad, NH) 
  4.0            (2H, s, NH2) 
 
           
Fig-36: UV Spectrum of compound SY4 
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Fig-37: IR Spectrum of compound SY4 
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Fig-38:  1H-NMR Spectrum of the compound SY4 
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6.2.5. Spectral analysis of 2-(4-nitrophenyl)-1H-benzimidazole: 
UV: (Fig-39) 
λmax (MeOH)       273.0 (ε max  0.4548) 
 IR (KBr): (Fig-40) 
Wave Number (Cm-1)                                                 Assignment 
3114.22      N-H stretching 
3062.21      C-H aromatic stretching 
1604.17      C-C skeletal stretching 
1541.85      N-O asymmetrical stretching 
1349.62      N-O symmetrical stretching 
1288.31      C-N stretching 
1127.45      C-H bending (in plane) 
878.93       C-H bending (out plane) 
NMR (MeOD): (Fig-41) 
    
N
N
H
N+
O
O-
7.70
7.70
7.26
7.26
5.0
8.25
8.25
7.74
7.74
  
(8 aromatic protons and 1 proton on nitrogen) 
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 δ                                                                     Assignment 
8.25              (2H, m, Ar-H- C3´&C5´) 
7.74              (2H, m, Ar-H- C2´&C6´) 
7.70                                                       (2H, m, Ar-H- C4&C7) 
7.26                                                       (2H, m, Ar-H- C5&C6) 
5.0                                                         (1H, s, broad, NH) 
            
 
                           Fig-39:  UV Spectrum of compound SY5 
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Fig-40: IR Spectrum of compound SY5 
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Fig-41: 1H- NMR Spectra of the compound SY5 
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 6.2.6. Spectral analysis of (5-nitro-1H-benzimidazol-2-yl) methane thiol: 
UV: (Fig-42) 
λmax (MeOH)                                  280 .0 (ε max 0.3040) 
IR (KBr): (Fig-43) 
Wave Number                                                            Assignment 
3072.23      Aromatic C-H stretching 
2933.61      S-H stretching 
1683.23      C-C ring stretching 
1584.92      N-O asymmetrical stretching 
1348.72      N-O symmetrical stretching 
1537.17      C=N stretching 
846.68       C-N stretching 
763.10       N-O bending  
715.23       C-S stretching 
NMR (MeOD): (Fig-44) 
N
N
H SH
N+
O
-O
8.63
7.96
8.19
5.0
3.82
1.5
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(3 aromatic protons, 2 aliphatic protons, 1 proton on nitrogen and one proton on sulphur) 
  δ                                                       Assignment 
8.63       (1H, s, Ar-H- C4) 
8.19       (1H, d, Ar-H- C6) 
7.96       (1H, d, Ar-H- C7) 
5.0                                                         (1H, s, broad, NH) 
3.82      (2H, s, CH2) 
1.5                    (1H, s, SH) 
                                     
Fig-42 : UV Spectrum of compound SY6 
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Fig-43:  IR Spectrum of compound SY6 
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Fig-44: 1H- NMR Spectra of the compound SY6 
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 6.2.7. Spectral analysis of 5-nitro 2-(propan-2-yl)-1H-benzimidazole: 
UV: (Fig-45) 
λmax (MeOH)                                 233.0 (ε max 0.1938) 
IR (KBr): (Fig-46) 
Wave Number                                                           Assignment                                                                                   
3384.19      N-H stretching 
3098.25      Aromatic C-H stretching 
1612.71      N-H bending 
1538.03      N-O asymmetrical stretching 
1348.03      N-O symmetrical stretching 
1217.67      C-N stretching 
883.21       C-C stretching 
755.96       C-H bending 
   NMR (MeOD): (Fig-47) 
N
N
H
N+
O
-O
8.63
7.96
8.19
5.0
3.12
1.29
1.29
 
(3 aromatic protons, 7 aliphatic protons, and 1 proton on nitrogen) 
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   δ                                                           Assignment 
8.63      (1H, s, Ar-H- C4) 
8.19      (1H, d, Ar-H- C6) 
7.96      (1H, d, Ar-H- C7) 
5.0                                                        (1H, s, broad, NH) 
3.12                 (1H, m, CH of isopropyl) 
1.29      (6H, d, 2CH3  of isopropyl) 
 
(Fig-45 : UV Spectrum of compound SY7) 
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Fig-46: IR Spectrum of compound SY7 
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Fig 47: 1H- NMR Spectra of the compound SY7 
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6.2.8. Spectral analysis of 5-nitro 2-butyl-1H-benzimidazole: 
UV: (Fig-48) 
λmax (MeOH)      244.0 (ε max   2.3824) 
IR (KBr): (Fig-49) 
Wave Number                                                           Assignment 
3651.02      N-H stretching 
3098.41      Aromatic C-H stretching 
1541.67      N-O asymmetrical stretching 
1344.16      N-O symmetrical stretching 
1456.09      C-H bending 
1209.52      C-N stretching 
892.90       C-C stretching 
751.82       C-H bending (Wagging) 
NMR (MeOD): (Fig-50) 
N
N
H
N+
O
-O
8.63
7.96
8.19
5.0
2.55
1.62
1.33
0.96  
(3 aromatic protons, 9 aliphatic protons, and 1 proton on nitrogen) 
 77 
 
 
 
 
  
        δ                                                               Assignment 
      8.63      (1H, s, Ar-H- C4) 
      8.19      (1H, d, Ar-H- C5) 
      7.96      (1H, d, Ar-H- C7) 
      5.0                                                         (1H, s, broad, NH) 
      2.55             (2H, t, CH2)                      
      1.62             (2H, m, CH2) 
      1.33             (2H, m, CH2) 
      0.96                  (3H, t, CH3) 
 
 
Fig- 48: UV Spectrum of compound SY8 
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Fig-49: IR Spectrum of compound SY8 
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Fig-50: 1H-NMR Spectra of the compound SY8 
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6.2.9. Spectral analysis of 4-(5-nitro-1H-benzimidazol-2-yl) aniline: 
UV: (Fig-51) 
λmax (MeOH)      313.0  (ε max  0.3320) 
IR (KBr): (Fig-52) 
Wave Number                                                           Assignment 
3418.50         N-H symmetrical stretching ( primary amine) 
3322.70         N-H stretching (secondary amine)  
3072.36         Aromatic C-H stretching 
1644.22         N-H bending    
1532.92         N-O asymmetrical stretching 
1344.12         N-O symmetrical stretching 
1231.34         C-N stretching 
 
NMR (MeOD): (Fig-53) 
N
N
H
NH2
N+
O
-O
8.63
7.96
8.19
5.0
6.52
6.52
7.23
7.23
4
.
0
 
(7 aromatic protons and three protons on nitrogen) 
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       δ                                                                 Assignment 
     8.63      (1H, s, Ar-H- C4) 
     8.19      (1H, d, Ar-H- C6) 
     7.96      (1H, d, Ar-H- C7) 
     7.23                 (2H, m, Ar-H- C2´&C6´) 
     6.52                (2H, m, Ar-H- C3´&C5´) 
     5.0                                                             (1H, s, broad, NH) 
     4.0                             (2H, s, NH2) 
   
 
Fig-51: UV spectrum of compound SY9 
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Fig-52: IR Spectrum of compound SY9 
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Fig-53: 1H- NMR Spectra of the compound SY9 
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6.2.10. Spectral analysis of 5-nitro 2-(4-nitrophenyl)-1H-benzimidazole: 
UV: (Fig-54) 
λmax (MeOH)      267.5 (ε max  0.9932) 
IR (KBr): (Fig-55) 
Wave Number (Cm-1)                                                Assignment 
3114.32      N-H stretching 
3061.87      Aromatic C-H stretching 
1698.28      N-O asymmetrical stretching 
1604.29      N-H bending 
1349.69      N-O symmetrical stretching 
1129.71          In plane bending of aromatics 
877.69       C-N stretching (nitro aromatics) 
859.46       Out of plane bending of aromatics 
  NMR (MeOD): (Fig-56) 
 
N
N
H
N+
O
O-
N+
O
-O
8.63
7.96
8.19
5.0
8.25
8.25
7.74
7.74
 
(7 aromatic protons and 1 proton on nitrogen) 
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         δ                                                               Assignment 
      8.63     (1H, s, Ar-H- C4) 
      8.25                (2H, m, Ar-H- C3´&C5´) 
      8.19     (1H, d, Ar-H- C6) 
      7.96     (1H, d, Ar-H- C7) 
      7.74                (2H, m, Ar-H- C2´&C6´) 
      5.0                                                             (1H, s, broad, NH) 
       
Fig-54: UV Spectrum of compound SY10
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Fig-55: IR Spectrum of compound SY10 
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Fig-56: 1H-NMR Spectra of the compound SY10 
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6.2.11. Spectral analysis of (5-amino-1H-benzimidazol-2-yl) methane thiol: 
UV: (Fig-58) 
λmax (DMF, MeOH)   275.0 (ε max  0.1927) 
 
IR (KBr): (Fig-59)  
Wave Number (Cm-1)                        Assignment 
3552.00    N-H asymmetrical stretching (primary amine) 
3416.86    N-H symmetrical stretching (primary amine) 
3376.18    N-H stretching (secondary amine) 
2852.0     C-H stretching 
2468.00    S-H stretching 
1622.56    N-H bending 
1448.97    C-H bending 
1394.26    C-C ring stretching 
1225.49    C-N stretching 
1065.25    C-H bending 
746.41     C-S stretching 
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NMR (DMSO – d6): (Fig-60) 
 
(3 aromatic protons, 2 aliphatic protons, 3 protons on nitrogen and 1 proton on sulphur) 
               δ                                                                  Assignment 
7.31      (1H, d, Ar-H- C7) 
6.70      (1H, s, Ar-H- C4) 
 6.62      (1H, d, Ar-H- C6) 
 5.0      (1H, s, NH) 
 4.03      (2H, s, CH2) 
 3.48      (2H, s, NH2) 
 1.68      (1H, s, SH) 
MASS: (Fig-61) 
The structure of the compound was further confirmed by its fragmentation peaks which 
are as follows: 
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N
N
H
SH
NH2 e- N
N
H
+
SH
NH2
m/z 179 (M+ peak)
N
N
H
+
SH
NH2 SH CH2 N
C
+
N
H
NH2
m/z 132 m/z 179 (M+ peak)
H CN
CH2
+
N
N
H
SH
m/z 152 
H N
N
H
SH
+
m/z 151
 
Fig-57: Fragmentation pattern of (5-amino-1H-benzimidazol-2-yl) methane thiol 
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Fig-58: UV Spectrum of compound SY11 
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Fig-59: IR Spectrum of compound SY11 
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Fig-60:  1H-NMR Spectrum of the compound SY11 
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 Fig-61: MASS Spectrum of the compound SY11
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6.2.12. Spectral analysis of 5-amino 2-(propan-2-yl)-1H-benzimidazole: 
UV: (Fig-63) 
λmax (DMF, MeOH)   272.5 (ε max  0.3374) 
IR (KBr): (Fig-64) 
Wave Number (Cm-1)                       Assignment 
3587.00    N-H asymmetrical stretching (primary amine)  
3218.00    N-H stretching (secondary amine) 
2343.00    C-H stretching 
1635.00    N-H bending 
1385.00    C-N stretching 
1129.00    C-H in plane bending of aromatics 
NMR (DMSO – d6): (Fig-65) 
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(3 aromatic protons, 7 aliphatic protons, and 3 protons on nitrogen) 
               δ                                                                 Assignment 
 7.31      (1H, d, Ar-H- C7) 
 6.69      (1H, s, Ar-H- C4) 
 6.61      (1H, d, Ar-H- C6) 
 5.0      (1H, s, NH) 
 3.48      (2H, s, NH2) 
 3.40      (1H, m, CH of isopropyl) 
 1.24      (6H, m, CH3 of isopropyl) 
MASS: (Fig-66) 
The structure of the compound was further confirmed by its fragmentation peaks which 
are as follows: 
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Fig-62: Fragmentation pattern of  5-amino 2-(propan-2-yl)-1H-benzimidazole 
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(Fig-63: UV Spectrum of compound SY12) 
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Fig-64:   IR Spectrum of compound SY12 
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Fig 65:  1H-NMR Spectrum of the compound SY12 
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Fig-66: MASS Spectrum of the compound SY12
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6.2.13. Spectral analysis of 5-amino 2-butyl-1H-benzimidazole: 
UV: (Fig-68) 
λmax (DMF, MeOH)   366.0 (ε max  0.1759) 
 
IR (KBr): (Fig-69) 
Wave Number (Cm-1)                       Assignment 
3573.00    N-H asymmetrical stretching (primary amines) 
3393.00    N-H stretching (secondary amines) 
2175.00    C-H stretching 
1648.00    N-H bending 
1397.00    C-N stretching 
1113.00    C-H bending (wagging) 
689.00     C-H bending (rocking) 
  NMR (DMSO – d6): (Fig-70) 
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(3 aromatic protons, 9 aliphatic protons, and 3 protons on nitrogen) 
               δ                                                                 Assignment 
7.31      (1H, d, Ar-H- C7) 
 6.69      (1H, s, Ar-H- C4) 
 6.61      (1H, d, Ar-H- C6)  
 5.0      (1H, s, NH) 
3.48      (2H, s, NH2) 
 2.86      (2H, t, CH2) 
 1.72      (2H, pent, CH2) 
 1.30      (2H, m, CH2) 
 0.90      (3H, t, CH3) 
MASS: (Fig-71) 
The structure of the compound was further confirmed by its fragmentation peaks which 
are as follows: 
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Fig-67: Fragmentation pattern of 5-amino 2-butyl-1H-benzimidazole 
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(Fig-68: UV Spectrum of compound SY13) 
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Fig-69: IR Spectrum of compound SY13 
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Fig-70: 1H-NMR Spectrum of the compound SY13 
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Fig-71: MASS Spectrum of the compound SY13 
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6.2.14. Spectral analysis of 5amino 2-(4-aminophenyl)-1H-benzimidazole: 
UV: (Fig-73) 
λmax (DMF, MeOH)   309.5 (ε max  0.2688) 
IR (KBr): (Fig-74) 
Wave Number (Cm-1)                        Assignment 
3579.00    N-H asymmetrical stretching (primary amine) 
3369.00    N-H stretching (secondary amine) 
1645.00    N-H bending 
1429.00    C-N stretching 
866.00     C-H bending 
657.00     C-H bending of aromatics 
NMR (DMSO – d6): (Fig-75) 
 
(7 aromatic protons and 5 protons on nitrogen) 
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              δ                                                          Assignment 
7.85      (2H, m, Ar-H- C2´&C6´) 
7.43      (1H, d, Ar-H- C7) 
6.85      (1H, s, Ar-H- C4) 
6.76      (1H, d, Ar-H- C6) 
6.59                (2H, m, Ar-H- C10&C12) 
5.0      (1H, s, NH) 
3.99      (2H, s, NH2) 
3.58      (2H, s, NH2) 
MASS: (Fig-76) 
The structure of the compound was further confirmed by its fragmentation peaks which 
are as follows: 
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Fig-72: Fragmentation pattern of 5 amino 2-(4-aminophenyl)-1H-benzimidazole 
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Fig-73: UV Spectrum of compound SY14
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Fig-74: IR Spectrum of compound SY14 
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 Fig-75: 1H-NMR Spectrum of the compound SY14 
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Fig-76: MASS Spectrum of the compound SY14
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6.2.15. Spectral analysis of 5-amino 2-(4-nitrophenyl)-1H-benzimidazole: 
UV: (Fig-78)  
λmax (DMF, MeOH)   270.0 (ε max  0.0392) 
IR (KBr): (Fig-79) 
Wave Number (Cm-1)                         Assignment 
3559.00    N-H asymmetrical stretching (primary amine) 
3432.00    N-H symmetrical stretching (primary amine) 
3206.00    N-H stretching (secondary amine) 
1632.00    N-H bending 
1596.00    N-O stretching 
864.00     Out of plane bending of aromatics  
795.00     C-H bending 
NMR (DMSO – d6): (Fig-80) 
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(7 aromatic protons and 3 protons on nitrogen) 
               δ                                                         Assignment 
8.28                 (2H, m, Ar-H- C3´&C5´) 
8.02      (2H, m, Ar-H- C2´&C6´) 
7. 44      (1H, d, Ar-H- C7) 
6.91      (1H, s, Ar-H- C4) 
6.82      (1H, d, Ar-H- C6) 
5.0      (1H, s, NH) 
3.58      (2H, s, NH2) 
 
MASS: (Fig-81) 
The structure of the compound was further confirmed by its fragmentation peaks which 
are as follows: 
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Fig-77: Fragmentation pattern of 5-amino 2-(4-nitrophenyl)-1H-benzimidazole 
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Fig-78: UV Spectrum of compound SY15
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Fig-79: IR Spectrum of compound SY15 
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 Fig-80:  1H-NMR Spectrum of the Compound SY15 
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Fig-81: MASS Spectrum of the compound SY15
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Table-1:  Physical and analytical data of the synthesized compounds 
Code Name Nature Solubility 
Molecular 
weight 
(gm) 
Molecular 
formula 
Melting 
Point 
(OC) 
Percentage 
Yield (%) 
Rf Value 
Methanol : 
water 
(8:2) 
SY1 
1H-benzimidazol-
2-yl methane thiol 
 
Dark 
green 
colour 
powder 
Freely soluble: Methanol, 
ethyl acetate, ethanol and 
acetone 
Sparingly soluble: 
water, benzene and 
chloroform 
164.22 C8H8N2S 162 37.94 0.79 
SY2 
2-(propan-2-yl)-
1H-benzimidazole 
 
Dark 
brown 
colour 
crystal 
Freely soluble: Methanol, 
ethanol, ethyl acetate, 
benzene, chloroform and 
acetone 
Sparingly soluble: water 
 
 
160.21 C10H12N2 112 39.94 0.85 
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SY3 
2-butyl-1H-
benzimidazole 
 
Light 
brown 
colour 
crystals 
Freely soluble: Methanol, 
ethyl acetate, ethanol and 
acetone 
Sparingly soluble: benzene, 
chloroform and  water 
174.24 C11H14N2 114 54.02 0.83 
SY4 
4-(1H-
benzimidazol-2-yl) 
aniline 
 
Pink 
colour 
solid 
Freely soluble: Methanol, 
ethyl acetate, benzene, 
chloroform and acetone 
Soluble: ethanol 
Sparingly soluble: hexane 
and water 
209.24 C13H11N3 
248 
(248-250) 
35.37 0.30 
SY5 
2-(4-nitrophenyl) -
1H-benzimidazole 
 
White 
colour 
powder 
Freely Soluble: Methanol 
and acetone 
Sparingly soluble: ethanol, 
ethyl acetate, hexane and 
water 
Very slightly soluble: 
benzene and chloroform 
239.23 C13H9N3O2 
254 
(254-256) 
31.38 0.58 
 125 
 
 
 
 
  
 
SY6 
(5-nitro-1H-
benzimidazol-2-yl) 
methane thiol 
 
Light 
yellow 
crystalline 
powder 
Soluble: Methanol and  
acetone 
Sparingly soluble:  ethyl 
acetate, chloroform and  
ethanol 
 
209.22 C8H7N3O2S 185 54.79 0.81 
SY7 
5-nitro 2-(propan-
2-yl)-1H-
benzimidazole 
 
Dark 
black 
colour 
solid 
Freely soluble: Methanol 
Sparingly soluble: ethyl 
acetate, acetone and ethanol 
Slightly soluble: benzene and 
chloroform 
 
205.21 C10H11N3O2 96 31.53 0.69 
SY8 
5-nitro 2-butyl-  
1H-benzimidazole 
 
Dark 
black 
colour 
solid 
Freely soluble: Methanol 
Sparingly soluble: ethanol 
and chloroform 
Slightly soluble: ethyl 
acetate and acetone 
 
219.24 C11H13N3O2 124 26.59 0.84 
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SY9 
4-(5-nitro-1H-
benzimidazol-2-yl) 
aniline 
 
Light 
yellow 
crystalline 
powder 
Soluble: Methanol and ethyl 
acetate 
Sparingly soluble: ethanol, 
acetone and  chloroform 
 
254.24 C13H10N4O2 216 30.09 0.81 
SY10 
5-nitro 2-(4-
nitrophenyl)-1H-
benzimidazole 
 
White 
colour 
powder 
Sparingly soluble: Methanol 
and ethanol 
Slightly soluble: ethyl 
acetate and water 
 
284.22 C13H8N404 226 39.54 0.58 
SY11 
(5-amino-1H-
benzimidazol-2-yl) 
methane thiol 
 
Light 
brown 
colour 
solid 
Freely soluble: 
Dimethylformamide and 
Dimethylsufoxide Sparingly 
soluble: methanol 
Slightly soluble: chloroform 
and benzene 
Very slightly soluble: 
ethanol, acetone and water 
179.24 C8H9N3S 261 44.04 0.78 
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SY12 
5-amino 2-
(propan-2-yl)-1H-
benzimidazole 
 
Black 
colour 
solid 
Freely soluble:  
Dimethylformamide and 
Dimethylsufoxide Soluble: 
Methanol 
Sparingly soluble: 
Chloroform and water 
Slightly soluble: Benzene 
and hexane 
175.23 C10H13N3 220 91.76 0.79 
SY13 
5-amino 2-butyl-
1H-benzimidazole 
 
Black 
colour 
solid 
Freely soluble:  
Dimethylformamide and 
Dimethylsufoxide  
Soluble: Methanol 
Sparingly soluble: 
Chloroform and water 
Slightly soluble: benzene, 
hexane, ethanol 
189.25 C11H15N3 238 93.02 0.80 
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SY14 
5-amino (4-
aminophenyl)-1H-
benzimidazole 
 
Dark 
black 
colour 
solid 
Freely soluble:  
Dimethylformamide and 
Dimethylsufoxide Sparingly 
soluble: methanol, water 
Slightly soluble: ethanol, 
benzene chloroform 
224.26 C13H12N4 255 86.36 0.72 
SY15 
5-amino 2-(4-
nitrophenyl)-1H-
benzimidazole 
 
White 
colour 
solid 
Freely soluble:  
Dimethylformamide and 
Dimethylsufoxide Soluble: 
chloroform 
Sparingly soluble: methanol, 
ethanol, acetone, water 
 
254.24 C13H10N4O2 277 39.14 0.76 
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Table-2:  Comparative physiochemical data of conventional and microwave assisted synthesized compounds 
Compound 
Conventional synthesis Microwave synthesis 
Reaction 
Time (h) 
% 
yield 
Melting 
Point (˚ C) 
Rf value 
Methanol 
: water 
(8:2) 
Reaction 
Time (h) 
% 
yield 
Melting 
Point (˚ C) 
Rf value 
Methanol : 
water 
(8:2) 
SY1 6-8 37.94 162 0.79 
2min 
20sec 91.75 164 0.79 
SY2 6-8 39.94 112 0.84 
1min 
30sec 89.01 116 0.83 
SY3 6-8 54.02 114 0.86 
1min 
15sec 84.83 118 0.86 
SY4 2 35.37 
248 
(248-250) 0.30 
6min 
30sec 82.44 252 0.31 
SY5 4 31.38 
254 
(254-256) 0.58 
8min 
30sec 88.63 258 0.57 
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6.4. a. Screening of anti-bacterial activity: 
 The synthesized compounds were evaluated for in vitro anti-bacterial activity 
against gram negative bacteria Proteus vulgaris NCTC 4635, Klesibella pneumonia 
ATCC 29655 and gram positive bacteria Bacillus cereus NL98, Enterococcus faecium 
ATCC 29212. These are the agents commonly causes urinary tract infection, nosocomial 
infection, biliary tract infection. The gram negative organism Klesibella pneumonia 
causes pneumonia, bronco pneumonia and bronchitis infection. The gram positive 
organisms Bacillus cereus and Enterococcus faecium cause endocarditis, bacteremia, 
meningitis and septicemia. As per the data obtained, it was confirmed that all the tested 
compounds possessed anti-bacterial activity against both gram positive and gram 
negative organisms. The SY11 showed the significant activity in following order Proteus 
vulgaris > Enterococcus faecium > Bacillus cereus > Klesibella pneumonia. The SY12 
showed the siginificant activity in the following order Bacillus cereus > Enterococcus 
faecium > Klesibella pneumonia > Proteus vulgaris. The compound SY13 showed the 
significant activity in the following order Proteus vulgaris > Klesibella pneumonia > 
Bacillus cereus > Enterococcus faecium. The SY14 showed the significant activity in the 
following order Klesibella pneumonia > Enterococcus faecium > Proteus vulgaris > 
Bacillus cereus. The SY15 showed the significant activity in following order Klesibella 
pneumonia > Bacillus cereus > Enterococcus faecium > Proteus vulgaris. SY11 
exhibited more potent activity against Proteus vulgaris. SY12 exhibited more potent 
activity towards Bacillus cereus. SY13 exhibited more potent activity towards Proteus 
vulgaris. SY14 exhibited more potent activity towards Klesibella pneumonia. SY15 
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exhibited more potent activity against Klesibella pneumonia. However the anti-bacterial 
activity of all the synthesized compounds against the tested organism was found to be 
less than that of Ciprofloxacin a standard drug at tested dose level. 
6.4. b. Screening of anti-fungal activity: 
The synthesized compounds were evaluated in-vitro anti-fungal activity against 
two fungal organisms Aspergillus niger and Aspergillus fumigatus. These are the 
organisms causes serious lungs infection, bronchitis, aspergillosis. As per the data 
obtained, it was confirmed that all the tested compounds possessed anti-fungal activity. 
However, SY12 exhibited potent anti-fungal activity against both fungal organisms among 
the all synthesized compounds. However the anti-fungal activity of the SY12 against the 
tested organism was found to be less than that of anti-fungal drug ketoconazole at tested 
dose level. 
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Table 3: In vitro anti-bacterial activity of synthesized compounds by disc diffusion method 
Microorganisms 
Diameter of  zone of inhibition in mm 
SY11  
(μg/disc) 
SY12 
(μg/disc) 
SY13 
(μg/disc) 
SY14 
(μg/disc) 
SY15 
(μg/disc) 
Ciprofloxacin 
(μg/disc) 
25 100 25 100 25 100 25 100 25 100 100 
Bacillus cereus 11 17 17 25.5 12 19 10 14.8 18 26 30 
Proteus vulgaris 12 18.5 12 15 21 25 11 16.4 12 17 28 
Klebsiella pneumonia 13 15 14 17 18 22.5 21 26 22 26.5 29 
Enterococcus faecium 15 18 14 17.6 11 14 17 21 17 24 28 
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Table 4: In vitro anti-fungal activity of synthesized compounds by disc diffusion method 
Microorganisms 
Diameter of  zone of inhibition in mm 
SY11 
(μg/disc) 
SY12 
(μg/disc) 
SY13 
(μg/disc) 
SY14 
(μg/disc) 
SY15 
(μg/disc) 
Ketoconazole 
(μg/disc) 
25 100 25 100 25 100 25 100 25 100 100 
Aspergillus niger 14 17.5 19 22 14 20 15 19.5 12 16.4 30 
Aspergillus  fumigatus 15 17 20 21 13 16 11 16.7 13 18 27 
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Fig-82: Anti-bacterial activity of synthesized compounds against tested organisms 
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Fig-83: Anti-fungal activity of synthesized compounds against tested organisms 
  
 
SUMMARY AND 
CONCLUSION 
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7. SUMMARY AND CONCLUSION 
 
In recent year attention has increasingly been given to the synthesis of 
benzimidazole derivatives as a source of new anti-microbial agents. The synthesis of 
novel benzimidazole derivatives remain a main focus of medicinal research. (Vijaya B. 
Reddy, et al., 2009) 
In order to expand the group of benzimidazole derivatives, we synthesized several 
new benzimidaole ring containing compounds. The O-phenylene diamine reacted with 
appropriate carboxylic acid under harsh dehydrating reaction condition to give the 
corresponding benzimidazole in good yield by Phillips reaction. The same was repeated 
by using microwave irradiation to give the corresponding benzimidazole in excellent 
yields. Then, a series of 5- nitro substituted benzimidazole derivatives were synthesized 
using nitration reaction by using Conc. HNO3 and Conc. H2SO4. Then 5-nitro substituted 
benzimidazoles were reduced by using a mixture of Zn/NaOH to give 5-amino 
substituted benzimidazoles. The purity of the synthesized compounds were checked by 
performing TLC (Rf) and determining melting points. Since our titled compounds were 
known to possess anti-microbial activity, the synthesized compounds were screened for 
their anti-bacterial and anti-fungal activity. 
 The structure of the synthesized compounds were established by spectral (IR, 1H 
NMR and Mass) analysis data. The NH band (3463-3114 cm-1) and NH proton signal 
(5.0 ppm) of 2-substituted benzimidazole in IR and 1H NMR spectrum respectively in 
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the synthesized compounds, (SY1-SY5) confirmed the formation of benzimidazole 
nucleus. In SY1, 1H NMR spectrum showed a 2 proton singlet at δ 1.5 and δ 3.82 for 3 
protons confirmed the presence of methane thiol group. In SY2, multiplet at δ 3.12 for 1 
proton and doublet at δ 1.29 for 6 protons indicated the formation of iso-propyl group. 
 In SY3, two triplet at δ 2.55 and 0.96 for 5 protons and two multiplet at δ 1.62 
and δ 1.37 for 4 protons indicated the presence of butyl group. In SY4, two multiplet at δ 
7.23-7.26 and δ 6.52 for 4 protons and a singlet at δ 4.0 for 2 protons indicated the 
presence of amino phenyl group. In the case of SY5, two multiplet at δ 8.25 and δ 7.74 
for 4 protons indicated the substitution of nitro phenyl group at C2 of benzimidazole 
nucleus. 
  The presence of nitro group in SY6-SY10 was ascertained from strong bands at 
1584 -1532 cm-1 and 1345 cm-1 corresponding to asymmetric and symmetric O=N=O 
stretch respectively. Further a strong intensity signal at 1231-846 cm-1 was attributed to 
the C-N stretching for aromatic nitro compounds. 
Spectrum of SY6-SY10 in the aromatic region indicated that the three chemical 
environments at δ 8.63, 8.19 and 7.96, instead of two regions which were present in 
SY1-SY5. The maximal downfield one proton singlet at δ 8.63 was assigned to C-4 
proton. The second proton (C-6), ortho to nitro group appeared at δ 8.19 as doublet (J = 
4.5 Hz) due to ortho coupling with C-7 proton. The remaining C-7 proton was observed 
as a one proton doublet at δ 7.96 (J= 8.8 Hz) due to ortho coupling with C-6 proton. 
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The presence of primary amino group in SY11-SY15 was ascertained from strong 
bands at 3500 cm-1 and 3400 cm-1 corresponding to asymmetric and symmetric H-N-H 
stretch respectively. Further a strong signal at 1648-1622 cm-1 was attributed to N-H 
bending for primary amino group. 
  In SY11 – SY15, a singlet at δ 3.48 for 2 protons indicated the presence of primary 
amino group. 
In the mass spectrum of the synthesized compounds produced (M+ ) Molecular ion 
peaks at  179.24, 175.23, 189.25, 224.26, 254.24 values for SY11, SY12, SY13, SY14 and 
SY15 respectively corresponds to their molecular formulas. The predicted chemical 
structure of titled compounds was further supported by the fragmentation peaks.  
 All the synthesized compounds exhibited good activity against the studied set of 
microorganisms. Since a fewer species have been used in this study, it is warranted to 
screen these compounds with varied species and resistant strains. All the compounds 
showed very good anti- bacterial and anti-fungal activity even at less concentration. 
From the data, it is evident that the compound SY15 is a most potent candidate against 
anti-bacterial studies and compound SY12 is a much potent candidate for anti-fungal 
studies. 
Even though, the antimicrobial activity of tested compounds was less than their 
standard compounds are ciprofloxacin (antibacterial) and ketoconazole (antifungal) in 
the present study. In future study, it could be increased (or) equalized by altering the 
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number of carbon atoms in side chain (or) introducing aromatic ring (or) substituted 
aromatic ring (or) heterocyclic ring (or) by introducing double bond in side chain in the 
2nd position of benzimidazole nucleus. 
Further experiments were needed to elucidate their exact mechanism of activity. 
These results suggest that the tested derivatives of benzimidazoles have excellent scope 
for further development as commercial anti-bacterial and anti-fungal agents. In future 
study the activity of the compounds may be manipulated by introducing unsaturation or 
heterocyclic ring at C2 of benzimidazole.  
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